Literature DB >> 8649226

Changes in high density lipoprotein subfraction lipids during neutral lipid transfer in healthy subjects and in patients with insulin-dependent diabetes mellitus.

M C Ritter1, J D Bagdade.   

Abstract

While it is known that the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to the apo B-containing lipoproteins is increased in patients with diabetes, the extent to which the various lipoprotein fractions engage in neutral lipid exchange and the magnitude to which triglyceride (TG) is translocated is not known. To examine in greater detail neutral lipid net mass transfer in diabetes, the HDL subfractions and the apo B-containing lipoproteins were separated, and the net mass transfer of CE and TG was compared to that of control subjects. In both groups, bidirectional transfer of CE from HDL3 to very low density lipoprotein (VLDL) + low density lipoprotein (LDL) and of TG from VLDL + LDL to HDL3, took place, but this process was significantly greater (P < .01) in insulin-dependent diabetes mellitus (IDDM). In contrast, CE and TG accumulated in HDL2 to a similar degree in normal and IDDM subjects. In recombination experiments with each of the apo B-containing lipoproteins, IDDM VLDL had a greater capacity to facilitate the exchange of core lipids from both IDDM and control HDL3: on the other hand, LDL from IDDM and control subjects both donated TG and CE to HDL2 and affected little change in HDL3. These findings indicate that all the major plasma fractions normally participate in the trafficking of CE and TG among the lipoproteins during neutral lipid transfer and show that the principal perturbation in cholesteryl ester transfer in IDDM involves altered interaction between VLDL and the HDL3 subfraction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649226     DOI: 10.1007/bf02522403

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  17 in total

1.  Initial steps in reverse cholesterol transport: the role of short-lived cholesterol acceptors.

Authors:  O L Francone; C J Fielding
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

Review 2.  Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

Authors:  D Reichl; N E Miller
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

Review 3.  Plasma lipid transfer proteins.

Authors:  A R Tall
Journal:  J Lipid Res       Date:  1986-04       Impact factor: 5.922

4.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

Authors:  A Inazu; M L Brown; C B Hesler; L B Agellon; J Koizumi; K Takata; Y Maruhama; H Mabuchi; A R Tall
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

5.  Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia.

Authors:  J D Bagdade; M C Ritter; P V Subbaiah
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

7.  Net mass transfer of cholesteryl esters from low density lipoproteins to high density lipoproteins in plasma from normolipidemic subjects.

Authors:  A Van Tol; L M Scheek; J E Groener
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

8.  Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus.

Authors:  J D Bagdade; M C Ritter; P V Subbaiah
Journal:  Eur J Clin Invest       Date:  1991-04       Impact factor: 4.686

9.  Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol.

Authors:  O L Francone; A Gurakar; C Fielding
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

10.  Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus.

Authors:  J D Bagdade; J T Lane; P V Subbaiah; M E Otto; M C Ritter
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.